The present study re-examined the involvement of the gustatory thalamus (GT) in the acquisition of drug-and toxin-induced conditioned taste aversions (CTAs) using a standardized procedure involving 15-min taste trials in rats injected with morphine (Experiment 1), lithium chloride (Experiment 2) or amphetamine (Experiment 3).
Introduction
Taste neophobia and conditioned taste aversion (CTA) are phenomena that defend against the ingestion of toxic foods. The former refers to the reluctance, in the absence of knowledge about post-ingestive consequences, to consume a new food (e.g., [7, 8, 10, 15] ) whereas the latter refers to the reduced intake of a food that is known to have aversive post-ingestive consequences (e.g., [6, 9, 39, 52] ). In the laboratory the oral (taste) and post-ingestive (visceral malaise) features of the toxic food are usually separated and termed, respectively, the conditioned stimulus (CS) and the unconditioned stimulus (US).
Because it is a taste-guided behavior, neurobehavioral investigations of CTA learning have tended to focus on the roles of the components of the central gustatory system (e.g., [46, 47, 48] ). In the rat, taste information is relayed from the parabrachial nucleus to the gustatory insular cortex (GC) via the gustatory thalamus (GT; for reviews see [36, 65] ). The present article is concerned with the role of the GT in CTA acquisition.
The overwhelming majority of studies that have examined the effects of GT lesions on CTA have employed a toxin (e.g., lithium chloride; LiCl) as the US (e.g., [19, 40, 49, 51, 59] ). Moreover, these studies uniformly found that GT lesions have no influence CTA acquisition. In marked contrast, however, there are two experiments that reported that GT lesions eliminated CTA acquisition [21, 53] . These latter two experiments are notably different from the former studies in that they used a rewarding dose of morphine (i.e., a dose that supports place preference learning) as the US. Together, this pattern of results encouraged the view that malaise-inducing toxins/poisons and rewarding drugs of abuse support qualitatively different types of taste learning dependent on different neural substrates (e.g., [21, 22] ).
The view that there are different forms of taste suppression that can be fractured apart by a neural manipulation (in this case, GT lesions) is critically dependent on all aspects of the behavioral procedures being the same, except, of course, the USs.
However, the two morphine experiments involved taste trials that were 5 min in duration whereas the aforementioned LiCl studies typically employed 15 min taste trials. It is, we believe, unsafe to form strong conclusions about the existence of different processes of taste suppression on the basis of experiments that used such short access periods. In particular, 5-min trials are prone to ceiling effects on intake (which is constrained to a maximum of about 10-12 ml) that might obscure differences that otherwise would be revealed when a longer trial duration is employed. The goal of the present study was to reexamine the role of the GT in taste suppression induced with a drug of abuse (Experiments 1 and 3) and LiCl (Experiment 2). To ensure comparability, 15-min trials were used in each experiment. If the GT has a significant role in drug-induced taste suppression then lesions of this nucleus should, like those reported by Grigson et al.
[ 21] and Reilly and Trifunovic [53] , eliminate this form of learning irrespective of trial duration. On the other hand, if a different outcome is obtained with 15-min taste trials then the role of the GT in taste learning requires reevaluation.
Experiment 1
As noted above, only two experiments, those reported by Grigson et al. [21] and
Reilly and Trifunovic [53] , have investigated the influence of GT lesions on the acquisition of drug-induced taste learning. Both of these experiments employed the same design that involved 5-min CS access per trial and a 15-mg/kg morphine US. In each experiment it was found that GT-lesioned (GTX) rats injected with the morphine US drank the same amount of the taste CS as the control GTX subjects injected with the saline vehicle. Thus, GTX rats conditioned with morphine failed to show any evidence of CS intake suppression. Experiment 1 re-examined the influence of GT lesions on drug-induced taste learning with a procedure that permitted 15-min saccharin access each trial and a 15-mg/kg morphine US.
Method
2.1.1 Subjects. Forty-one, experimentally naïve, male Sprague-Dawley rats (275 -300 g) obtained from Charles River Laboratories (Wilmington, MA) served as subjects.
They were individually housed in stainless steel hanging cages (Acme Metal Product, Chicago, IL) in a vivarium maintained at 21C on a 12 hr light-dark cycle (lights on at 7:00 am). Animals were allowed to habituate to the facility for 3 -5 days before surgery.
All experimental treatments and procedures were conducted during the light phase of the cycle. Food and water were available at all times in the home cage except during behavioral testing as noted below. Animals were treated in accordance with guidelines from the American Psychological Association [2] and the National Institutes of Health [43] . The University of Illinois at Chicago Institutional Animal Care and Users Committee approval was obtained for all treatments.
Surgery.
A total of 20 rats received bilateral GT lesions using the procedures of Sastre and Reilly [58] . These animals (Group GTX) were anesthetized with intraperitoneal (IP) injections of sodium pentobarbital (55 mg/kg) and secured in a Kopf Model 1900 stereotaxic instrument equipped with a digital readout (David Kopf
Instruments, La Jolla, CA) using non-traumatic earbars. Cranial sutures were exposed by a midline incision; a single trephine hole (5 mm diameter) was drilled on the skull centered over the transverse sinus at the level of the GT. Excitotoxic lesions were created with 0.15 M N-methyl-D-aspartate (Sigma-Aldrich; St Louis, MO) backfilled into a glass micropipette (tip diameter ~70 m) and infused iontophoretically into the GT with a Midgard precision current source (Stoelting, Wood Dale, IL). There was a single 6 min -10 A current infusion per hemisphere at -3.70 mm posterior to bregma, 0.80 mm medial/lateral to the midline, -6.30 mm ventral to dura. Body temperature was monitored throughout the surgical procedure via a rectal thermometer and maintained at 37C with a heating pad (Harvard Apparatus, Holliston, MA). Twenty-one rats served as control subjects (Group SHAM): 10 rats received the same surgical procedures as GTX rats except no N-methyl-D-aspartate was infused and 11 rats received only pentobarbital anesthesia.
Apparatus.
All testing was conducted in the home cage with fluids presented in plastic graduated cylinders fitted with silicone stoppers and stainless steel sipper tubes secured to the front of the home cage by stainless steel springs. Volumes were measured to the nearest 0.5 ml.
Procedure.
The rats were acclimated to a deprivation schedule permitting 15 min access to water each day. The experiment began when water intake stabilized (12 days) at which time the rats in each group (SHAM and GTX) were divided into subgroups according to the drug (saline or morphine) to be administered as the US on conditioning days. Each conditioning trial consisted of 15 min access to 0.15% saccharin followed, 5 min later, by an IP injection of either physiological saline (1 ml/kg body weight) or morphine sulfate (15 mg/ml/kg). A saccharin trial occurred every third day and the rats were otherwise maintained on the water deprivation schedule as described above. ---INSERT FIGURE 1 ABOUT HERE ---Complete bilateral destruction of the GT was required for rats to be included in statistical analyses of Group GTX (see Figure 1 ). Of the rats that were included some minor damage extended into the centromedian, paracentral, parafasicular, and subparafasicular thalamic nuclei, as well as the VPM, but damage was unilateral and non-systematic in all animals. Misplaced lesions tended to be placed dorsolateral to the GT resulting in subtotal GT damage while increasing damage to the VPM, centromedian nucleus, and paracentral nucleus. Groups included in the behavioral analysis were:
SHAM-Saline (n = 11), SHAM-Morphine (n = 10), GTX-Saline (n = 8), and GTX-
GT Lesions in the current study were comparable in size and locus to those in our earlier work (e.g., [58, 49, 53, 54] ).
Behavioral.
---INSERT This lesion effect persisted across all trials (ps < .01) such that on Trial 5 the GTXMorphine (12.14 ±2.08 ml) rats consumed 5.4 ml more of the CS than the SHAMMorphine (6.7 ±1.70 ml) subjects. Thus, relative to intake on Trial 1, each of the groups reduced CS intake by a similar amount across conditioning trials, suggesting that SHAM and GTX rats acquired a morphine-induced CTA at a comparable rate and of comparable magnitude.
The pattern of results in the morphine-injected rats is reminiscent of the results obtained in neurologically intact rats by Lin et al. [29] . In that study, normal rats acquired a morphine-induced CTA to a saccharin CS that was either novel or, due to prior saccharin exposure, familiar. Subjects familiarized with the CS before conditioning with a morphine US had, as expected, a much higher initial intake than their novel counterparts and, not surprisingly, showed a latent inhibition-induced delay in CTA acquisition. Of particular interest to present purposes, the final asymptotic level of morphine-induced CTA was significantly higher in rats conditioned with a familiar saccharin CS relative to those conditioned with a novel saccharin CS (~18 and ~6 ml, respectively). Thus, each group showed a similar absolute conditioned reduction in CS consumption of about 7 -8 ml in the Lin et al. study. These data suggest that, for druginduced CTAs, the final level of CS intake is dependent on whether the taste is novel or familiar on the first conditioning trial. Returning to the present results, the GTX-Morphine rats also displayed significantly higher CS intake at asymptote than the SHAM-Morphine subjects, which would seem to suggest that the GT lesions influenced some aspect of novelty perception or responsivity. This analysis is also supported by the lesion-induced elevation of saccharin intake on Trial 1. However, the present results also revealed that the across-trial conditioned reduction of CS intake was virtually identical in the SHAMMorphine and GTX-Morphine rats.
Experiment 2
The results obtained in Experiment 1 were surprising in a number of ways, not least of which was the occurrence of a GT lesion-induced deficit in taste neophobia.
Also surprising, this neophobia deficit had no subsequent influence on the rate of taste learning. We have previously reported that lesions of the GC, the cortical taste area, not only disrupt taste neophobia in a manner comparable to that reported here for GT lesions, but that the neophobia deficit consequently retarded taste learning in the GC lesioned rats [29, 56, 57] . Thus, the pattern of results obtained in Experiment 1
encouraged a re-examination of the effect of GT lesions on LiCl-induced CTA acquisition. Experiment 2 investigated this issue using two different designs. Using half of the rats from Experiment 1, Experiment 2A employed our standard CTA procedures with 15-min unrestricted access to the taste CS on all trials. This design provides another opportunity to determine whether GT lesions influence the magnitude of the expected neophobic reaction on Trial 1 and, if that deficit does occur, whether it has an influence on the acquisition of a CTA induced with LiCl toxicosis. Experiment 2B was similar in design to Experiment 2A, except CS intake was capped on Trial 1 to prevent lesion-induced intake differences that may otherwise occur from confounding interpretation of CTA acquisition rate in the GTX rats. Quinine (0.0001 M) was selected as the taste CS in Experiment 2 for its ability to reliably evoke a neophobic reaction.
Due to the magnitude of this neophobic response 5 ml was selected as the intake cap in Experiment 2B.
Methods
3.1.1 Subjects, surgery, and apparatus. The same subjects and apparatus from Experiment 1 were used in Experiment 2. They were housed, maintained and tested in the same manner as during Experiment 1 except for procedural differences described below.
Procedure.
Following completion of Experiment 1, the rats were given 7 days free access to food and water, and were then divided into two groups of 20 (Experiment 2A) and 21 (Experiment 2B) animals, respectively, counterbalanced according to lesion and prior drug condition. Water intake was re-stabilized.
Conditioning trials were conducted every third day with two water days intervening.
Conditioning trials consisted of presentations of 0.0001 M quinine for 15-min (Experiment 2A) or 15-min to a maximum of 5 ml intake (Experiment 2B). Fifteen min after the quinine bottles were removed all rats received an IP injection of LiCl (13.3 ml/kg of 0.15 M LiCl). Because of the rate of acquisition, two conditioning trials were followed by a taste only test trial. The dependent measure was volume of quinine consumed.
Data analysis and histology. Histology and data analysis procedures
were identical to those used for Experiment 1.
Results and Discussion

Anatomical.
The histological analysis for this set of rats was presented in Experiment 1. Consequent to that analysis, the number of rats in each experiment were:
SHAM n = 10, GTX n = 8 in Experiment 2A and SHAM n = 11, GTX = 8 in Experiment 2B.
Behavioral.
The mean amount of water consumed over the three days preceding Trial 1 for all animals included in the behavioral analysis are summarized in a trend (p = .07) toward a decrease (~1) ml on the final baseline water day. Overall, these analyses indicate that GT lesions did not influence water intake, which was stable between groups for the three days prior to the first conditioning trial of each experiment.
---INSERT FIGURE 3 ABOUT HERE ---
The behavioral data obtained in Experiment 2 are shown in Figure 3 . Analysis of the data summarized in Figure 3A for Experiment 2A revealed a significant main effect intake on Trial 2 (ps < .00001), and there were no group differences on Trial 2 (F < 1).
Each group further suppressed intake on Trial 3, again with no between-group differences (F < 1). An ANOVA of the data summarized in Figure 3B for Experiment 2B revealed a significant main effect of Trial, F(2,32) = 68.58, p < .0001. There was, however, no significant main effect of Group (F < 1) and no Group x Trial interaction (F < 1). A Tukey test showed a significant decrease from Trial 1 to Trial 2 and from Trial 2 to Trial 3 (ps < .01). Thus, when Trial 1 intake was equated there were no differences between SHAM and GTX animals in the rate of acquisition for a LiCl-induced CTA.
Overall, the results of Experiment 2 replicated the neophobia deficits found in the GTX rats in Experiment 1 and also replicated prior work showing that GT lesions have no influence on the acquisition of LiCl-induced CTAs.
Experiment 3
The two prior experiments that examined GT lesions and drug-induced taste learning employed morphine as the US [21, 53] . There are, however, important differences in the mechanism of action and effect profiles of drugs of abuse (e.g., [4] ).
By using a different drug US, amphetamine, in a second set of experimentally naïve rats Experiment 3 was intended to extend the generality of the results obtained in Experiment 1. In addition, recent work in our laboratory, using lick pattern analysis, has revealed that palatability not only increases as taste neophobia habituates but that the palatability of a taste CS decreases following taste-drug pairings [3, 27, 30] . To further investigate the effects of GT lesions on taste neophobia and drug-induced CTA, Experiment 3 was conducted in drinking chambers to permit a microstructural analysis of fluid intake.
When rats voluntarily drink they do so in sustained bursts of rapid licks termed clusters, each cluster separated by pauses. The size of clusters (i.e., the mean number of licks in a cluster) has been validated as a measure of taste palatability that is independent of total intake (e.g., [11, 12, 13, 14, 23, 62, 63] , for a review see [17] ).
Specifically, as the concentration of sweet solutions (e.g., sucrose and Polycose) increase so too does cluster size although, of course, there is an inverted U-shaped curve for volume consumed. On the other hand, clusters size decreases with increasing concentration of bitter solutions (e.g., quinine). Furthermore, clusters size has been used to detect downshifts in taste palatability induced by contingent administration of illness-inducing USs [3, 5, 16, 18, 24] and, as mentioned above, by drug of abuse USs.
Method
Subjects and surgery.
Forty experimentally naïve male Sprague-Dawley rats were acquired and housed in a manner identical to Experiment 1. Surgical procedures were also identical to those employed in Experiment 1, except 24 rats served in Group GTX. A shaded light bulb (100 mA, 28 V) mounted on the sidewall opposite to the sipper tube provided illumination in the chamber. Each chamber was equipped with a white noise generator (~80 dB). Chambers were connected to a computer in an adjacent room, which controlled all events and records data using programs written in the Medstate notation language.
Apparatus. Eight identical modular drinking chamber (Med
Procedure.
Following surgery the rats were given at least 10 days to recuperate. Thereafter, they were placed on a water deprivation schedule (15 min access to water each day in the home cages) and habituated to the drinking boxes (15 min per day). After three such days, the 15-min daily water access periods were switched into the drinking chamber. The subjects were divided into four groups based on lesion (SHAM or GTX) and US (saline or amphetamine) yielding the following groups: SHAM-Saline, SHAM-Amphetamine, GTX-Saline, and GTX-Amphetamine.
Conditioning trials commenced when water intake patterns stabilized across all groups and all dependent measures for three consecutive days. Conditioning trials occurred in a three-day cycle based on the nature of the US injection. On Day 1, experimental rats were injected with amphetamine (1 mg/kg) 5 min after 15-min access to the saccharin CS whereas unpaired control subjects were injected with an equivalent volume of physiological saline. On Day 2, 5 min after 15 min water access the rats were injected with the other US (saline or amphetamine, respectively; a balanced design that ensures all rats had equal exposure to saline and amphetamine). On Day 3, all rats were given 15-min access to water; no USs were administered. Conditioning trials continued until stable performance emerged in the experimental and control groups. Thus, there were a total of three taste-amphetamine conditioning trials and a single CS only test trial (on which the amphetamine was omitted as superfluous).
Dependent measures.
Two dependent measures were computed: volume consumed (determined by weighing stimulus bottles before and after each session) and lick cluster size (calculated by dividing the total number of licks occurring in clusters by the total number of clusters; a cluster was defined as a run of licks separated by interlick intervals of less than 0.5 s).
Data analysis and histology. The procedures for histology and data
analysis were identical to those described for Experiment 1.
Results and Discussion
Anatomical.
Damage to the GT and surrounding areas was comparable to that reported in the GTX rats in Experiment 1, except the lesions were somewhat larger.
In the rats with acceptable lesions, minor damage extended from the GT into the centromedian, paracentral, parafasicular, and subparafasicular thalamic nuclei, as well as the VPM. This damage was unilateral and non-systematic across GTX animals. A total of five animals were dropped from Group GTX due to lesions that did not completely destroy the GT bilaterally. As in the first set of rats misplaced lesions appeared to primarily damage areas dorsolateral to the GT. Thus, a majority of the GT was spared while the VPM, centromedian nucleus, paracentral nucleus, and thalamic trigeminal orosensory area sustained significant damaged. Groups included in statistical analyses were: SHAM-Saline (n = 8), SHAM-Amphetamine (n = 8), GTX-Saline (n = 9), and GTX-Amphetamine (n = 10).
Behavioral.
Water intake data from the final three baseline trials are summarized in Table 1 . Separate ANOVAs were conducted on intake and cluster size and found no significant difference of any type (all ps > .15). Thus, GT lesions had no influence on water consumption and the performance of all four groups was stable over the three water days prior to the first conditioning trial. habituates in neurologically intact rats ( [27] , see also [3, 30] ). The lack of a significant decline in lick cluster size in the SHAM-Amphetamine group was surprising given recent findings that amphetamine significantly reduced cluster size when paired, in separate experiments, with either a quinine, saccharin, sodium chloride or an aqueous odor as the CS [3, 30] . Notwithstanding this anomalous performance in the SHAM-Amphetamine group, the amphetamine US caused a substantial reduction in lick cluster size in the GTX rats from ~150 on Trial 1 to ~25 on Trial 4.
As with Experiment 1 (morphine) and Experiment 2 (LiCl), the overall pattern of results in Experiment 3 demonstrates that GT lesions do not eliminate CTA, in this case to an amphetamine US. Thus, Experiment 3 adds generality to the view that GT lesions do not disrupt drug-induced CTAs. The reduction in the palatability of the taste CS in the GTX-Amphetamine group, consistent with our previous findings in normal animals [3, 30] , indicates that GT lesions do not disrupt this aspect of drug-induced CTA. Intake and palatability of the saccharin solution tracked upward in the SHAM-Saline rats with the attenuation of taste neophobia, as has been previously demonstrated in normal animals [27] . Interestingly, the neophobia deficit in GTX animals was expressed as a Trial 1 elevation in both intake and palatability. Importantly, this apparent taste familiarity in the GTX-Amphetamine rats on Trial 1 did not result in a latent inhibition-like delay in CTA acquisition, as found in normal rats conditioned with a familiar taste CS (e.g., [29] ; for a latent inhibition review see [35] ). of LiCl-induced CTAs. It appears that the earlier work suggesting that the GT may be a critical neural substrate for drug-induced taste learning might have employed a design that was not optimal. That is, we are inclined to the view that the 5-min trials (which limit intake to 10-12 ml) were of insufficient duration to detect the intake suppression induced by the morphine US in rats with GT lesions. Indeed, the present research suggests that the GT is not critical for the acquisition of CTAs produced by morphine, amphetamine or LiCl.
GENERAL DISCUSSION
On the other hand, the GT has a role in the unconditioned reaction to a novel taste stimulus on the initial encounter. Thus far, we have termed this deficit a disruption of taste neophobia. However, given that the GT is a component nucleus in the central gustatory system, perhaps the most obvious interpretation of this finding is a lesioninduced deficit in taste perception. In particular, the present results might be taken to suggest that GT lesions are causing the rats to respond as if taste stimuli were less intense or concentrated. That said, to our knowledge, there is no evidence supportive of this account in the literature. Indeed, the evidence would seem to refute such an interpretation. For example, Reilly and Pritchard [50] used both long (24 hr, two-bottle) and short (15 min, single bottle) duration tests and found normal taste response curves for hydrochloric acid, quinine, sodium chloride and sucrose in GTX rats. Similarly, Flynn, Grill, Schwartz, and Norgren [20] found normal concentration response curves in GTX rats for hydrochloric acid, quinine, sodium chloride and sucrose during one-bottle, 15-min intake tests. Finally, Scalera et al. The present results not only reverse this oversight but they also bring other evidence into sharper focus with regard to an involvement of the GT in taste neophobia. That it, using analysis of c-Fos activation, Lin, Roman, Arthurs, and Reilly [31] recently found that in addition to the GC, basolateral amygdala (BLA), and central nucleus of the 1 Some prior research [34, 66] is suggestive of such a deficit in GTX rats. However, as noted in a review of the role of the GT in taste-guided behavior [46] , close inspection of the histological results reveals that the electrolytic lesions in the Loullis et al. study were, in fact, located dorsal to, and thus spared, the GT. The Yamamoto et al. experiment involves an opposite type of anatomical problem. That is, the ibotenic acid lesions were exceptionally large spreading so far beyond the boundaries of the GT and causing significant damage to many other structures as to defy meaningful attribution of function to structure. amygdala, the GT was also activated by exposure to a novel, but not a familiar, taste stimulus. Furthermore, in a voluntary intake task involving 15-min trials, Lin et al. [27] reported that palatability (assessed with lick cluster size) was significantly lower when the tastant was novel relative to when the same stimulus was familiar as a consequence of repeated exposures. The finding that taste novelty/familiarity modulates palatability fits well with the result from the present Experiment 3 showing that the elevated intake expressed by GTX rats on first encounter with the saccharin tastant was accompanied by a cluster size that was more representative of a familiar than a novel taste. These lines of evidence converge to encourage the view that GT lesions disrupt a process necessary for the occurrence of taste neophobia.
The GT is reciprocally connected with the GC [26, 42] , which is also reciprocally connected with the BLA [37, 45, 61] . Of particular relevance to present purposes, bilateral lesions of either the GC or BLA disrupt taste neophobia which is characterized by an elevated intake of the novel taste stimulus on first encounter and a subsequent latent inhibition-like delay in the acquisition of CTAs [25, 32, 30, 33, 57, 41, 64] . A similar elevated consumption of a novel taste CS was seen in the GTX rats in the present study but this deficit appeared to have no influence on the rate of taste aversion learning.
Interestingly, bilateral lesions of the medial amygdala (MeA) disrupt the initial expression of taste neophobia [33] but are reported to have no influence of CTA acquisition [1, 38, 55, 60, 66] . Finally, a recent study employing asymmetric unilateral lesions of the GC, BLA or MeA revealed that the GC and BLA form a functional unit in terms of the initial expression of taste neophobia; asymmetric unilateral lesions of the MeA and GC or MeA and BLA had no influence on taste neophobia [28] . In sum, bilateral lesions of either the GC or BLA disrupt taste neophobia and delay CTA acquisition whereas bilateral lesions of the GT or the MeA disrupt taste neophobia but have no influence on CTA learning. Together, these results support the view that taste neophobia may involve at least two processes manifest as (i) elevated initial intake (and an increase in taste palatability) and (ii) delayed taste learning. Furthermore, the GT appears to be involved in the former but not the latter of these processes. Using the approach of Lin and Reilly [28] , it will be of some theoretical importance to determine if asymmetric unilateral lesions of the GT and MeA produce deficits in taste neophobia comparable to those seen following bilateral lesions of either structure alone. Such an outcome would lead to a better understanding of the neural substrates of taste neophobia and encourage further research to determine the nature of that functional unit relative to the GC-BLA unit identified by Lin and Reilly.
The current report has in one sense succeeded in clarifying the role of the GT in taste learning. That is, we now know that lesions of the GT do not eliminate druginduced CTA. In fact, if GT lesions have any influence on CTA acquisition induced with drugs of abuse or toxins that influence appears to be minor. In another sense, the current investigation has only begun to characterize the role of the GT in taste neophobia. Note. Values presented are the means (±SE) from the final three water trials before the first conditioning trial of each experiment. Abbreviations: fr = fasiculus retroflexus; GT = gustatory thalamus; ml = medial lemniscus; pf = parafasicular nucleus. 
